Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 6,199,600 shares, an increase of 13.0% from the August 15th total of 5,488,000 shares. Based on an average daily trading volume, of 1,072,900 shares, the short-interest ratio is presently 5.8 days.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $6.25 target price on shares of Curaleaf in a research report on Thursday, August 8th. Cormark raised Curaleaf from a “hold” rating to a “moderate buy” rating in a research report on Monday, August 12th.
Read Our Latest Stock Report on Curaleaf
Curaleaf Price Performance
Curaleaf (OTCMKTS:CURLF – Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01). The firm had revenue of $342.29 million for the quarter, compared to analyst estimates of $344.57 million. Curaleaf had a negative net margin of 18.59% and a negative return on equity of 14.75%. Analysts forecast that Curaleaf will post -0.24 EPS for the current fiscal year.
Curaleaf Company Profile
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Further Reading
- Five stocks we like better than Curaleaf
- 3 Stocks to Consider Buying in October
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Health Care Stocks Explained: Why You Might Want to Invest
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.